Aehr Test Systems (AEHR)
NasdaqCM · Price as of · Delayed Quote
- Profitability0/20
Losing money: $-7.1M net income over the last four reported quarters. Revenue over the last four reported quarters was $50.0M, down 17% from $59.9M the year before.
- Insider buying vs selling11/20
Insiders are sellers only: 18 sells worth $17.3M, no open-market buys, across the last 20 Form 4s. Routine executive selling is common, so this is only a mild negative. Separately, 1 new 5%+ stake disclosure (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings6/15
Share count up 9.0% in a year plus 2 offering-related filings. Real dilution. One nuance: offerings raise cash that can fund real growth. The score docks the certain near-term dilution; if the spending pays off, it shows up later in the profitability component.
- Analysts4
- Implied upside+50.7%
- Target range$110.00 to $175.00
- EPS expected$0.09 +833%
- A year ago$0.01
- Revenue expected$26.6M +143%
- Estimate range$0.07 to $0.11
AEHR closed at $86.26 on Sep 4, down 13.5% since Aug 6. Chart read: price above the 200-day moving average but below the 50-day; the 50-day is above the 200-day (uptrend structure); trading at 53% of the 52-week range ($19.40 to $145.61).
Insider buying and selling at Aehr Test Systems (AEHR)
The most recent Form 4 on record for Aehr Test Systems (AEHR) is August 12, 2026, when Gayn Erickson, President and CEO, sold $5.2M of stock. Nothing in the filing ties this one to a pre-arranged plan, so it was the filer's own call.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Gayn Erickson · President and CEO | Sell | $5.2M | August 12, 2026 | Own call |
| Geoffrey Gates Scott · Director | Sell | $2.6M | August 12, 2026 | Own call |
| Howard T Slayen · Director | Sell | $2.2M | August 4, 2026 | Own call |
| Alberto Salamone · EVP, PPBI BUSINESS | Sell | $2.8M | April 20, 2026 | Own call |
| Geoffrey Gates Scott · Director | Sell | $5.7M | April 21, 2026 | Own call |
Filed notices to sell
A Form 144 is filed beforean insider sells restricted stock. The Form 4 reporting the completed trade isn't due until two business days after the sale, so these land first. They are intentions, not transactions.
| Insider | Value | Filed | Status | Type |
|---|---|---|---|---|
| ROGERS VERNON · Officer | $574,217 | August 17, 2026 | Executed | Vested shares |
| POSEDEL RHEA J · Director | $836,220 | August 14, 2026 | Executed | Vested shares |
| ROGERS VERNON · Officer | $273,000 | August 14, 2026 | Not yet reported | Vested shares |
| SLAYEN HOWARD T · Director | $753,911 | August 14, 2026 | Executed | Own call |
| SALAMONE ALBERTO · Officer | $1.2M | August 13, 2026 | Executed | Vested shares |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | September 3, 2026 | PRIMARY DOCUMENT |
| 4 | September 1, 2026 | PRIMARY DOCUMENT |
| 4 | August 18, 2026 | PRIMARY DOCUMENT |
| 144 | August 17, 2026 | View on EDGAR |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| SCHEDULE 13G/A | August 14, 2026 | View on EDGAR |
Aehr Test Systems news
All 10 articles
Aehr (AEHR) is up over 500% on the year, and five insiders just sold $11.15 million without a trading plan
On Aug. 12, five Aehr insiders including the CEO, the COO and the company's founder sold 85,130 shares for $11.15 million, and every one of them picked the date without a trading plan.
Aehr Test Systems (AEHR) director bought 20,000 shares at $15.50. He just filed to sell the same block near $109.
Fourteen insiders filed notices to sell stock on Tuesday. Thirteen were selling shares the company gave them. The fourteenth, a director at Aehr Test Systems, was selling 20,000 shares he bought himself at $15.50 two years ago.
Articles that mention Aehr Test Systems without it being the main subject.
AI stock battle week 7: DeepSeek leads our AI stock contest. All four of its latest picks broke the rules (September 5, 2026)
DeepSeek tried to sell C3.ai and buy four stocks. Two were over the $10 billion ceiling, two were too illiquid, and it wanted eight names in a five-stock contest.
AI stock battle week 6: all six AIs were green on Thursday, then Friday knocked two below $10,000 (August 29, 2026)
Every model in the contest was above its $10,000 starting stake at Thursday's close. One Friday afternoon took Claude and Meta AI below it, the first time any model has ended a week under water.
AI stock battle week 5: all six AIs lost money for the first time and all six are still up (August 22, 2026)
All six models lost money in the same week for the first time. Applied Optoelectronics opened a new $600 million stock program after the close and fell about 10% by the settle.
Frequently asked questions
When does AEHR report earnings?
Aehr Test Systems (AEHR) is scheduled to report quarterly results on October 8, 2026, after the close. The 3-analyst consensus is $0.09 per share on revenue of $26.6M for the quarter ended August 31, 2026, against $0.01 and $11.0M a year earlier.
What do analysts expect for AEHR?
4 analysts cover Aehr Test Systems (AEHR). No consensus rating has been published. The average price target is $130.00, in a range of $110.00 to $175.00.
Are insiders buying or selling AEHR?
We track Form 4 filings for Aehr Test Systems (AEHR). The activity listed on this page shows 5 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see AEHR SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed September 3, 2026.